fda glp-1 warning news september 2025 The U.S. health regulator asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound. https://cnn.it/49uSrKw FDA Approves Orforglipron, First GLP-1

Research confirms how common this struggle is: only 20% of women return to their pre-pregnancy weight within the first three months postpartum, and about 24% of women retain at least 10 pounds a year after giving birth

Results build gradually, in a fairly predictable order

Yes, and many of our Melbourne clients do exactly that

At one point, Sophia pulled up an old photo on her phone of her mother when she was still using drugs: Massarones face looked hollow, her eyes glassy and veiled by heavy mascara

And so to me, I think thats enough side effects where you need to look closely to see if the consumer has been warned about those side effects so they know what side effects they should look out for

In December 2025 the companys Wegovy pill became the first oral GLP-1 medication to be approved by the U.S